Resting energy expenditure and metabolic parameters in small for gestational age moderately preterm infants.

AIMS: The purpose of the present study was to analyze resting energy expenditure (REE), hormonal parameters and lipid profile in small for gestational age (SGA) moderately preterm infants compared to their appropriate for gestational age (AGA) counterparts in the first week after birth. METHODS: REE was measured in all participants using indirect calorimetry. Blood samples of all infants were collected at the same study point together with indirect calorimetry measurements. RESULTS: A total of 32 infants including 16 preterm infants born SGA and 16 AGA preterm neonates were recruited for the study, with a mean gestational age of 35 ± 1 weeks in both groups. REE values in the SGA group were significantly increased compared to the AGA group data after birth (p < 0.002). Low-density lipoprotein levels from the AGA group were significantly higher (p = 0.002) when compared to the SGA infants. No other clinical differences in hormonal parameters, lipid profile or blood pressure levels were identified between the two groups. CONCLUSIONS: In addition to low birth weight, intrauterine growth retardation is associated with a statistically significant increase in REE in SGA moderately premature infants shortly after birth, which requires further investigation when establishing nutritional recommendations in this cohort.

Effects of budesonide inhalation on energy expenditure, somatic growth and salivary cortisol levels in preterm infants with chronic lung disease.

BACKGROUND: We hypothesized that the use of inhaled budesonide (BUD) would alter somatic growth by increasing energy expenditure (EE) in premature infants with chronic lung disease (CLD). METHODS: A prospective study was conducted of the effect of BUD on EE, growth and salivary cortisol excretion in infants with CLD who required supplemental oxygen and were treated with inhaled BUD for 4 weeks according the severity of their CLD, or without BUD treatment. Infants were compared with a healthy control group matched for gestational age. EE, anthropometric measures and salivary cortisol levels were examined before, during and after BUD treatment. RESULTS: A total of 30 spontaneously breathing premature infants were enrolled in the study. EE in CLD (BUD) and CLD (no BUD) patients were greater than EE in healthy preterm infants (p < 0.01) at the study time points. Growth did not differ between the groups. Salivary cortisol levels of treated infants were significantly lower when compared with the levels of nontreated infants. CONCLUSION: The administration of inhaled BUD in preterm infants with CLD was associated with an increase in EE, a suppression of endogenous cortisol production and with no effect on duration of supplemental oxygen, but did not compromise their somatic growth.

Energy expenditure in neonates with Down syndrome.

Resting energy expenditure was measured in term neonates with Down syndrome during the first week of life and compared with healthy neonates. Infants with Down syndrome expended 14% fewer calories than did healthy infants of the same age.

Energy expenditure and plasma catecholamines in preterm infants with mild chronic lung disease.

The present study examined the hypothesis that the energy expenditure (EE) increases during the development of chronic lung disease (CLD) together with serum catecholamines as indicator of stress. Sixteen spontaneously breathing infants with gestational age of 28-34 weeks and birth weight of 870-1920 g were studied. Eight patients were at risk for CLD, eight were healthy controls. Measurements of indirect calorimetry were done weekly at postnatal ages of 2, 3, 4 and 5 weeks. Serum concentrations of adrenaline and noradrenaline were measured by means of a high-pressure liquid chromatography (HPLC) method. The eight CLD risk infants developed mild CLD with FiO(2) of 0.27-0.31 and characteristic radiographic signs at 28 days. Compared to the healthy controls, preterm infants with mild CLD showed increases in EE from week 3 (+67%) to week 5 (+46%). Plasma noradrenaline was increased significantly in the CLD infants when compared to the controls at week 3 (0.7+/-0.3 vs. 0.5+/-0.1 ng/ml; P<0.05) and more pronounced at week 4 (1.4+/-0.2 vs. 0.6+/-0.2 ng/ml; P<0.001) and 5 (1.1+/-0.3 vs. 0.7+/-0.2 ng/ml; P<0.01). Plasma adrenaline was markedly higher in the CLD risk group (mean overall value: 0.64+/-0.1 ng/ml) than in the controls (<0.1 ng/ml in all controls) from week 2 to 5. Regression analysis for the combined values of the infants with and without CLD showed that EE was directly correlated with heart rate, noradrenaline and adrenaline concentration at each of the four study weeks and with respiratory rate at weeks 2 and 3. Increased plasma catecholamine concentrations in preterm infants with CLD suggest that these infants experienced marked stress during the early stages of the disease. Increased EE may in part be a result of this stress.

Longitudinal evaluation of energy expenditure in preterm infants with birth weight less than 1000 g.

The aim of the present study was to obtain serial values of O2 consumption (VO2), CO2 production (VCO2) and energy expenditure (EE) in healthy but extremely-low-birth-weight infants (birth weight <1000 g), during the first 5 weeks after birth. A total of seventeen spontaneously breathing and appropriate-for-gestational-age (birth weight and body length above the 10th and below the 90th percentile) preterm infants with gestational age 25-28 weeks and birth weight 590-990 g were enrolled in the study. Calorimetry was performed using an open-circuit calorimeter on days 6, 12, 18, 24, 30 and 36 of postnatal life. During the 5 weeks of observation, VO2 increased from 4.7 (SD 0.5) to 9.1 (SD 1.0) ml/kg per min, VCO2 from 4.5 (SD 0.4) to 8.3 (SD 0.6) ml/kg per min and EE from 115 (SD 12) to 310 (SD 71) kJ/kg per d. The energy intake was always higher than EE, even at days 6 and 12. The RER decreased from 0.99 (SD 0.09) at day 12 to 0.91 (SD 0.05) at day 30. On all study days, there were highly significant positive correlations between energy intake and weight gain, EE and weight gain, and EE and energy intake (P<0.05). Multiple regression analysis showed that on most study days EE was more affected by energy intake than by weight gain. We conclude that in healthy preterm infants with birth weight <1000 g, EE increases by about 150 % in the first 5 weeks after birth, and that the EE values are related to energy intake and weight gain independent of postnatal age.

Effect of sepsis syndrome on neonatal oxygen consumption and energy expenditure.

OBJECTIVE: To evaluate oxygen consumption (VO2), carbon dioxide production, and energy expenditure (EE) in full-term neonates with early-onset neonatal septicemia daily for 7 days beginning at the day of clinical diagnosis of sepsis. METHODS: A total of 17 spontaneously breathing full-term neonates, 10 with clinical signs of sepsis and 7 healthy neonates (control group), were enrolled in the study. Age at first study day was 3 +/- 0.9 days in both groups. Sepsis syndrome was defined as a systemic response to a bacterial infection with clinical signs of infection, elevated values of interleukins 6 and 8 and C-reactive protein, and abnormal white blood cell count and positive blood cultures (9 group B streptococci, 1 Escherichia coli). Measurements of VO2 and carbon dioxide production were performed daily for 7 days by means of indirect calorimetry. RESULTS: In the septic infants, VO2 and EE were increased by about 20% at days 1 to 3 and by 15% at day 4 when compared with the controls. From days 1 to 3, EE averaged 57 +/- 3 kcal/kg/d in the septic neonates and 47 +/- 2 kcal/kg/d in the controls. At day 4, EE was 55 +/- 2 and 47 +/- 2 kcal/kg/d, respectively. Energy intake was about the same in both groups, whereas weight gain during the 7 study days was significantly lower in the sick patients than in the control group (19 +/- 2 g/d vs 33 +/- 9 g/d and 5.4 +/- 0.5 g/kg/d vs 9.4 +/- 2.6 g/kg/d, respectively). Increased EE was associated with increased heart rate (126 +/- 4 vs 112 +/- 4 min(-1) at day 1) and respiratory rate (56 +/- 6 vs 40 +/- 4 min(-1) at day 1). There were no differences in rectal temperature (37.3 +/- 0.4 degrees C vs 37.4 +/- 0.2 degrees C), skin temperature (36.5 +/- 0.4 degrees C vs 36.6 +/- 0.3 degrees C), and oxygen saturation (96 +/- 3% vs 96 +/- 3%) between the 2 groups. CONCLUSIONS: Neonates with sepsis syndrome have elevated VO2 and EE values that could explain impaired growth during the illness period and may make the infants vulnerable to insufficient calorie supply during the acute phase of septic disease.